2 ratings / 4 average

Therapeutics Research

Song IH, Hermann K, Haibel H et al. Ann Rheum  Dis 2011;70:590–6.

Magnetic resonance imaging scanning demonstrates greater improvement in spinal, sacroiliac, and entheseal inflammation with etanercept than with sulfasalazine in early axial spondyloarthropathy, consistent with clinical outcomes.

 

Magnetic resonance imaging (MRI) has been shown to be a sensitive tool for identifying improvement in sacroiliac and spinal inflammation in ankylosing spondylitis (AS) patients treated with tumor necrosis factor (TNF) inhibitors. In this study, the authors looked at whether MRI could be used to identify improvement in inflammation at sites of entheseal inflammation as well.

Return to top

LATEST ARTICLES